PDIA6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.232800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.469000E-01
Normal-vs-Stage2
4.726200E-01
Normal-vs-Stage3
8.047600E-01
Normal-vs-Stage4
2.908400E-01
Stage1-vs-Stage2
2.714200E-01
Stage1-vs-Stage3
7.896600E-01
Stage1-vs-Stage4
1.324220E-01
Stage2-vs-Stage3
2.395600E-01
Stage2-vs-Stage4
3.340600E-01
Stage3-vs-Stage4
1.800150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.244000E-01
Normal-vs-AfricanAmerican
9.866300E-02
Normal-vs-Asian
8.237200E-01
Caucasian-vs-AfricanAmerican
1.886790E-01
Caucasian-vs-Asian
1.229170E-01
AfricanAmerican-vs-Asian
7.461700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.207800E-01
Normal-vs-Female
5.202800E-01
Male-vs-Female
7.853800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.903000E-01
Normal-vs-Age(41-60Yrs)
2.747600E-01
Normal-vs-Age(61-80Yrs)
6.605200E-01
Normal-vs-Age(81-100Yrs)
4.235800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.773800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.493200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.460200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.544400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.541400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.206400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.096400E-01
Normal-vs-Daily Drinker
7.119800E-01
Normal-vs-Weekly Drinker
8.073000E-01
Normal-vs-Occasional Drinker
2.236200E-01
Normal-vs-Social Drinker
5.325200E-01
Non Drinker-vs-Daily Drinker
9.431800E-01
Non Drinker-vs-Weekly Drinker
9.759400E-01
Non Drinker-vs-Occasional Drinker
6.647900E-02
Non Drinker-vs-Social Drinker
5.910400E-01
Daily Drinker-vs-Weekly Drinker
9.388600E-01
Daily Drinker-vs-Occasional Drinker
1.122640E-01
Daily Drinker-vs-Social Drinker
6.715400E-01
Weekly Drinker-vs-Occasional Drinker
1.885970E-01
Weekly Drinker-vs-Social Drinker
6.888000E-01
Occasional Drinker-vs-Social Drinker
2.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.328800E-01
Normal-vs-Grade 2
8.337600E-01
Normal-vs-Grade 3
3.490600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.253800E-01
Grade 1-vs-Grade 3
2.268300E-02
Grade 1-vs-Grade 4
8.328800E-01
Grade 2-vs-Grade 3
4.592200E-02
Grade 2-vs-Grade 4
8.337600E-01
Grade 3-vs-Grade 4
3.490600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.346400E-01
Normal-vs-NonDiabetic
5.642800E-01
Diabetic-vs-NonDiabetic
8.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.157200E-01
Normal-vs-NoPancreatitis
5.490600E-01
Pancreatitis-vs-NoPancreatitis
8.724000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.779600E-01
Normal-vs-N1
4.720200E-01
N0-vs-N1
2.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.573800E-01
Normal-vs-TP53-NonMutant
7.179600E-01
TP53-Mutant-vs-TP53-NonMutant
6.939200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
